MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study.
about
Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpineNeurobiology of conditioning to drugs of abuse.Distinct neurochemical adaptations within the nucleus accumbens produced by a history of self-administered vs non-contingently administered intravenous methamphetamineBehavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.Effects of selective calcium-permeable AMPA receptor blockade by IEM 1460 on psychotomimetic-induced hyperactivity in the mouse.Methamphetamine treatment affects blood and liver S-adenosylmethionine (SAM) in mice. Correlation with dopamine depletion in the striatum.Alterations in striatal dopamine overflow during rotational behavior induced by amphetamine, phencyclidine, and MK-801.MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens.Enkephalin as a Pivotal Player in Neuroadaptations Related to Psychostimulant Addiction.
P2860
Q28378688-B90375F2-071D-4678-83CB-8BB4C52460CAQ34236434-5A44366C-81B0-459D-BBAB-2C220679B05EQ35679959-F18BA613-20DA-4D43-82AA-1E51453DDF99Q41851245-381A9571-445E-4730-A9A1-E9D4454A8065Q42034477-02178853-5768-445E-A3A7-3BCBCD7ADB19Q46690279-5DB0BEB6-FAC9-4993-8742-0FB867ABBCBFQ47899912-C13495B4-368A-48CA-AD4C-2F743D21AC57Q48428356-9BE0ABCF-B1A7-4634-B5E0-8B3AD9860FF0Q48679840-601F3A57-2BBF-4589-8B73-03338B8CBBF6Q48906983-A874F0B1-06FD-420B-AAFE-4BC8AF747431Q55266051-6998F4E3-0401-41B8-A385-5642E8548271
P2860
MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
MK-801 attenuates the dopamine ...... n in vivo microdialysis study.
@en
MK-801 attenuates the dopamine ...... n in vivo microdialysis study.
@nl
type
label
MK-801 attenuates the dopamine ...... n in vivo microdialysis study.
@en
MK-801 attenuates the dopamine ...... n in vivo microdialysis study.
@nl
prefLabel
MK-801 attenuates the dopamine ...... n in vivo microdialysis study.
@en
MK-801 attenuates the dopamine ...... n in vivo microdialysis study.
@nl
P2093
P1433
P1476
MK-801 attenuates the dopamine ...... n in vivo microdialysis study.
@en
P2093
Marshall JF
Weihmuller FB
P304
P356
10.1016/0006-8993(91)90462-5
P407
P577
1991-05-01T00:00:00Z